Abstract LB068: Oral fulvestrant nanoparticles deliver high, sustained exposure: An alternative to IM injection

作者
Richard A Graves,Hossain Ahamed,Changde Zhang,Guangdi Wang,Tarun K. Mandal
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:86 (8_Supplement): LB068-LB068
标识
DOI:10.1158/1538-7445.am2026-lb068
摘要

Abstract Background: Fulvestrant, a selective estrogen receptor degrader (SERD) for ER⁺ breast cancer, is available only as a monthly intramuscular (IM) injection in a viscous formulation that can be painful, and no oral product is available. Oral fulvestrant could improve convenience and adherence; however, extreme hydrophobicity and extensive first-pass metabolism have limited prior oral approaches. We developed an oral fulvestrant formulation based on nanoparticles composed of pharmaceutically acceptable natural lipids. Methods: Fulvestrant was incorporated into nanoscale natural-lipid particles using solvent-assisted mixing and sonication, followed by drying to yield a free-flowing powder suitable for oral capsule or tablet formulation. Female Sprague-Dawley rats received 10 mg/kg fulvestrant orally as the natural-lipid nanoparticle formulation. Serial blood samples were collected up to 216 h. Fulvestrant concentrations in plasma and whole blood were quantified by validated LC-MS/MS, and noncompartmental pharmacokinetic analysis was performed. Results: The oral natural-lipid formulation produced stable nanoscale particles (100-200 nm) with a narrow size distribution and favorable surface charge (−34.1 mV) in aqueous media. After oral administration of 10 mg/kg fulvestrant, plasma concentrations peaked at ∼505 ng/mL at 72 h, with AUC₀-₇₂h ≈ 1.4 × 10⁴ ng·h/mL. Exposure was persistent, with fulvestrant remaining quantifiable at 216 h (C₂₁₆h 110 ng/mL in plasma; 140 ng/mL in whole blood). Peak concentrations of 510 ng/mL (72 h, plasma) and 470 ng/mL (120 h, whole blood) were observed. A second composition with increased natural-lipid content also achieved high systemic exposure (plasma AUC₀-₇₂h 9.28 × 10³ ng·h/mL), supporting robustness to formulation optimization. Conclusions: A natural-lipid nanoparticle formulation achieved high and sustained systemic exposure of fulvestrant after a single oral dose in rats. Absolute bioavailability was not determined because intravenous fulvestrant dosing is not feasible due to poor aqueous solubility, and relative bioavailability could not be assessed because no oral reference formulation yields quantifiable systemic exposure; therefore, pharmacokinetic evaluation focused on systemic exposure following oral administration. The formulation uses pharmaceutically acceptable natural lipids and standard unit operations (mixing, drying, milling) and yields a free-flowing powder suitable for solid oral dosage forms. These findings support further evaluation and optimization of oral delivery for fulvestrant and other highly insoluble compounds. A U.S. provisional patent application covering the formulation and manufacturing process has been filed. Funding: Supported by NIH/NIMHD grant 2U54MD007595. Citation Format: Richard A. Graves, Hossain Ahamed, Changde Zhang, Guangdi Wang, Tarun K. Mandal. Oral fulvestrant nanoparticles deliver high, sustained exposure: An alternative to IM injection [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(8_Suppl):Abstract nr LB068.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
王大锤发布了新的文献求助10
刚刚
1秒前
1秒前
ttt完成签到,获得积分10
1秒前
半圭为璋发布了新的文献求助10
2秒前
2秒前
虚幻如容发布了新的文献求助10
2秒前
2秒前
卓卓完成签到,获得积分10
4秒前
4秒前
鸽子二号完成签到,获得积分10
4秒前
6秒前
月半完成签到 ,获得积分10
6秒前
隐形曼青的应助被啊琴黎采纳,获得10
6秒前
wangyiyi发布了新的文献求助30
7秒前
mengfeiyang发布了新的文献求助10
7秒前
7秒前
8秒前
8秒前
8秒前
8秒前
甘草次酸完成签到,获得积分10
8秒前
8秒前
含蓄的小鸽子完成签到,获得积分10
8秒前
科研通AI6.3的应助被海鹏采纳,获得10
9秒前
9秒前
9秒前
wanci的应助被Keoki采纳,获得10
9秒前
盐盐发布了新的文献求助10
10秒前
天天快乐的应助被ALITTLE采纳,获得10
10秒前
Happy发布了新的文献求助10
11秒前
11秒前
半圭为璋完成签到,获得积分10
12秒前
生菜发布了新的文献求助10
12秒前
英俊的铭的应助被阿咸采纳,获得10
12秒前
科研通AI6.3的应助被杨颖采纳,获得10
14秒前
ding的应助被花花牛不是牛采纳,获得30
14秒前
CNS发布了新的文献求助10
15秒前
15秒前
CJX完成签到,获得积分20
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178617
求助须知:如何正确求助?哪些是违规求助? 9569413
关于积分的说明 21804370
捐赠科研通 7773649
什么是DOI,文献DOI怎么找? 3432878
关于科研通互助平台的介绍 2556873
邀请新用户注册赠送积分活动 2478478